Can monitoring of intrathoracic impedance reduce morbidity and mortality in patients with chronic heart failure? Rationale and design of the Diagnostic Outcome Trial in Heart Failure (DOT-HF).
about
Current and future technologies for remote monitoring in cardiology and evidence from trial data.Fluid status monitoring with a wireless network to reduce cardiovascular-related hospitalizations and mortality in heart failure: rationale and design of the OptiLink HF Study (Optimization of Heart Failure Management using OptiVol Fluid Status MoniPotential value of automated daily screening of cardiac resynchronization therapy defibrillator diagnostics for prediction of major cardiovascular events: results from Home-CARE (Home Monitoring in Cardiac Resynchronization Therapy) study.Home telemonitoring in patients with chronic heart failure: a chance to improve patient care?Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care MediManagement of patients receiving implantable cardiac defibrillator shocks: recommendations for acute and long-term patient management.Device monitoring strategies in acute heart failure syndromes.Technology-assisted congestive heart failure care.Novel devices to monitor heart failure and minimize hospitalizations.Design of the evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO) study to assess the ability of remote monitoring to treat and triage patients more effectively.Loop diuretic therapy in left ventricular systolic dysfunction: has familiarity bred contempt for a critical but potentially nephrotoxic cardio renal therapy?Clinical trials update from the American College of Cardiology meeting 2010: DOSE, ASPIRE, CONNECT, STICH, STOP-AF, CABANA, RACE II, EVEREST II, ACCORD, and NAVIGATOR.Telemonitoring for heart failure: the only feasible option for good universal care?Clinical trials update from the Heart Failure Society of America Meeting 2009: FAST, IMPROVE-HF, COACH galectin-3 substudy, HF-ACTION nuclear substudy, DAD-HF, and MARVEL-1.Telemedical Interventional Monitoring in Heart Failure (TIM-HF), a randomized, controlled intervention trial investigating the impact of telemedicine on mortality in ambulatory patients with heart failure: study design.Effect of a telemonitoring-facilitated collaboration between general practitioner and heart failure clinic on mortality and rehospitalization rates in severe heart failure: the TEMA-HF 1 (TElemonitoring in the MAnagement of Heart Failure) study.Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial.Monitoring of Daily Body Weight and Intrathoracic Impedance in Heart Failure Patients With a High Risk of Volume Overload Decompensation.Midsummer Eve in Sweden: a natural fluid challenge in patients with heart failure.Assessment of a novel device-based diagnostic algorithm to monitor patient status in moderate-to-severe heart failure: rationale and design of the CLEPSYDRA study.Analysis of left ventricular impedance in comparison with ultrasound images.
P2860
Q34285229-9844BA38-5B7C-4AD8-84E6-A3D94A1A488CQ35073703-64568D78-B1A9-4F34-9339-77EA79C3D0F9Q35170240-882B3AAB-B891-4839-9F9E-FF4C8F65BED9Q37714341-8DA39C60-381A-4FDF-B964-1BBCA6B28C4FQ37721628-EC0D84B9-7532-4FA7-AF3B-A7EE11F0D883Q37803046-7071D5B2-B0B1-4D0A-9A55-D6829241D55AQ37855610-B196FF09-A6B7-410E-9EEB-1C28B433124BQ38317252-7AFC4799-DD73-4435-8635-73299E062036Q38827596-EC49E278-F8D7-41F4-BFBE-F6B9D0EC2B3DQ42160803-87C49FD7-97F0-45D2-BBCD-785AC4CFAD72Q43006146-4281F8E8-22CE-4B8A-9398-F3ACEFC1C0F5Q43055364-A4C5F577-6239-4CAF-9DD6-17F08E1CBFD2Q43178435-4628F384-E12B-47AC-9447-1A5E6AE2C80FQ43204655-DA329931-B61A-4823-9FCE-2F5D407424AEQ45180067-EC56AB06-8E97-4717-BBCF-A33F5DDF4BC8Q45382854-D4509D92-7B55-4C77-A257-75856D65F072Q45805237-4E1733AF-B3ED-4B39-9334-728328794B95Q47304262-AF46B54A-CB05-49EE-ABAE-EAB958688FA8Q51524674-AB2CBD24-2B67-4E61-B629-6A608717B216Q51647651-EFAC24BC-A1B2-477B-B8FB-154E4BCB1C8EQ53393924-8B7D2C28-2E0C-404C-8045-4A5BAC156DBD
P2860
Can monitoring of intrathoracic impedance reduce morbidity and mortality in patients with chronic heart failure? Rationale and design of the Diagnostic Outcome Trial in Heart Failure (DOT-HF).
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Can monitoring of intrathoraci ...... ial in Heart Failure (DOT-HF).
@en
Can monitoring of intrathoraci ...... Outcome Trial in Heart Failure
@nl
type
label
Can monitoring of intrathoraci ...... ial in Heart Failure (DOT-HF).
@en
Can monitoring of intrathoraci ...... Outcome Trial in Heart Failure
@nl
prefLabel
Can monitoring of intrathoraci ...... ial in Heart Failure (DOT-HF).
@en
Can monitoring of intrathoraci ...... Outcome Trial in Heart Failure
@nl
P2093
P2860
P1476
Can monitoring of intrathoraci ...... ial in Heart Failure (DOT-HF).
@en
P2093
Cheuk Man Yu
DOT-HF steering committee and investigators
Frieder Braunschweig
Guillaume Jondeau
Josef Kautzner
Martin R Cowie
Maurizio Lunati
Monique Marijianowski
Roberto Munoz Aguilera
P2860
P304
P356
10.1016/J.EJHEART.2008.06.016
P577
2008-08-19T00:00:00Z